Related Experiment Video
Updated: Aug 31, 2025

Author Spotlight: Cardiac Cell Transgenesis for Rapid Gene Screening
Published on: May 24, 2024
Electroporation Parameters for Human Cardiomyocyte Ablation In Vitro.
Jara M Baena-Montes1,2, Tony O'Halloran3, Cormac Clarke3
1Cellular Physiology Research Laboratory, CÚRAM SFI Centre for Research in Medical Devices, School of Medicine, Human Biology Building, National University of Ireland (NUI), H91 W5P7 Galway, Ireland.
Irreversible electroporation (IRE) shows promise for cardiac ablation. This study identified optimal IRE parameters for human cardiomyocyte cell death, demonstrating lesion size can be controlled for atrial fibrillation treatment.
Area of Science:
- Cardiovascular Science
- Biophysics
- Cell Biology
Background:
- Irreversible electroporation (IRE) is emerging as a preferred method for atrial fibrillation treatment.
- IRE offers potential for reduced collateral damage and improved cell targeting compared to other energy sources.
- Optimized, cell-specific parameters for human tissues are needed for IRE ablation.
Purpose of the Study:
- To determine optimal irreversible electroporation (IRE) parameters for inducing human cardiomyocyte cell death.
- To establish the relationship between IRE parameters and lesion size in human cardiomyocytes.
- To investigate the impact of varying pulse durations and field strengths on cell death dynamics.
Main Methods:
- Human AC16 cardiomyocytes were cultured in a 2D monolayer system.
- Conventional biphasic pulses with varying field strengths and on-times were applied.
- Cell death dynamics and lesion dimensions were analyzed at different time points post-ablation.
Main Results:
- Human cardiomyocytes underwent significant cell death at 750 V/cm with 100 μs pulses.
- Increasing IRE on-time from 3 ms to 60 ms lowered the threshold to 250 V/cm.
- Shorter pulses (2-5 μs) required higher fields (>1000 V/cm) for cell death; longer on-times increased cell death and lesion size.
Conclusions:
- IRE parameters can be precisely tuned to control lesion size and human cardiomyocyte cell death.
- Delayed cell death (24h post-electroporation) in cardiomyocytes is a key consideration for clinical application of IRE.
- This research provides critical data for optimizing IRE protocols in cardiac ablation therapies.
More Related Videos
08:23High-Throughput Capable Three-Dimensional Tissue Model for Quantification of Electroporation Thresholds
Published on: August 19, 2025
10:12Monitoring Electroporation-Induced Changes in Action Potential Generation in Genetically Engineered Tet-On Spiking HEK cells
Published on: September 6, 2024